DANSK FARMACEUTISK INDUSTRI A/S — Credit Rating and Financial Key Figures

DANSK FARMACEUTISK INDUSTRI A/S (CVR number: 10224675) is a company from EGEDAL. The company recorded a gross profit of 18.4 mDKK in 2023. The operating profit was 14.7 mDKK, while net earnings were 11.2 mDKK. The profitability of the company measured by Return on Assets (ROA) was 46.5 %, which can be considered excellent and Return on Equity (ROE) was 106 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 57.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. DANSK FARMACEUTISK INDUSTRI A/S's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.